Indivior Pharmaceuticals, Inc. (INDV)
Health Care ยท Pharmaceutical Preparations
Indivior Pharmaceuticals, Inc. (INDV) is listed on Nasdaq, where its shares have traded since December 24, 2014. SentiSense covers Indivior Pharmaceuticals, Inc. in the Health Care sector, and its Standard Industrial Classification is Pharmaceutical Preparations. Joe Ciaffoni is its chief executive officer. The company reports 838 employees, and its corporate website is www.indivior.com.
About Indivior Pharmaceuticals, Inc.
Indivior Pharmaceuticals Inc is a specialty pharmaceutical company singularly focused on delivering evidence-based treatment and advancing understanding of opioid use disorder (OUD) as a chronic but treatable brain disease. The company derives revenues from customers through the development, manufacture and sale of buprenorphine-based prescription drugs for treatment of opioid dependence and related disorders. The company's products include: Sublocade (buprenorphine extended-release monthly injection), and Suboxone (buprenorphine and naloxone sublingual film).
Latest reported results
Indivior reported revenue of $356.0 million for Q3 FY2026, up 13.4% from the same period a year earlier.
Institutional ownership
In 13F filings for the quarter ended June 30, 2026, 326 institutions reported holding INDV, with 120.9 million shares worth $5.0 billion in aggregate. The largest reported holders were BlackRock, Vanguard and Oaktree Capital Management. Of the 5 largest reported holders, 3 added shares and 2 reduced their positions during the quarter.
More on INDV
- INDV sentiment: whether news and social coverage of Indivior Pharmaceuticals, Inc. leans bullish or bearish, and the stories driving it.
- INDV ownership: all 326 reporting institutions, plus insider and congressional trades.
- INDV financials: revenue, net income, operating margin and free cash flow through Q3 FY2026.
SentiSense also tracks daily options readings for Indivior Pharmaceuticals, Inc.: IV rank, put/call percentile, 25-delta skew and open-interest walls.
Frequently asked questions
What does Indivior Pharmaceuticals, Inc. do?
Indivior Pharmaceuticals Inc is a specialty pharmaceutical company singularly focused on delivering evidence-based treatment and advancing understanding of opioid use disorder (OUD) as a chronic but treatable brain disease.
What sector is INDV in?
SentiSense classifies Indivior Pharmaceuticals, Inc. in the Health Care sector, and its Standard Industrial Classification is Pharmaceutical Preparations.
Where does INDV stock trade?
Indivior Pharmaceuticals, Inc. (INDV) is listed on Nasdaq, where its shares have traded since December 24, 2014.
Who is the CEO of Indivior Pharmaceuticals, Inc.?
Joe Ciaffoni is the chief executive officer of Indivior Pharmaceuticals, Inc..